Phase I trial of systemic administration of edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

A. Dispenzieri, C. Tong, B. Laplant, M. Q. Lacy, K. Laumann, D. Dingli, Y. Zhou, M. J. Federspiel, M. A. Gertz, S. Hayman, F. Buadi, M. O'Connor, V. J. Lowe, K. W. Peng, S. J. Russell

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of systemic administration of edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences